my guess is NOXCOVID has provided very limited or no convincing proof of efficacy to make it worth pursuing Covid further and will be quietly side lined//
//anyway even if turned out there is something worth researching they’d be better off getting this into one of the big adaptive trials like “recovery”. Otherwise I don’t see anybody having appetite to conduct larger Covid trial with this drug.
AIMO.
Ann: NOX and US Govt Peak Cancer Agency Announce Collaboration, page-8
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
